According to Torrent Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is NZ$2.23 Billion. In 2024 the company made a revenue of NZ$2.34 Billion an increase over the revenue in the year 2023 that were of NZ$1.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | NZ$2.25 B | -3.62% |
2024 | NZ$2.34 B | 18.65% |
2023 | NZ$1.97 B | 9.69% |
2022 | NZ$1.79 B | 10.62% |
2021 | NZ$1.62 B | 10.85% |
2020 | NZ$1.46 B | -9.87% |
2019 | NZ$1.62 B | 2.93% |
2018 | NZ$1.58 B | 31.07% |
2017 | NZ$1.20 B | -3.42% |
2016 | NZ$1.24 B | -10.83% |
2015 | NZ$1.40 B | 44.5% |
2014 | NZ$0.96 B | 30.96% |
2013 | NZ$0.74 B | 12.19% |
2012 | NZ$0.65 B |